Clinical Trial Update: Zanubrutinib in Participants With Active Proliferative Lupus Nephritis [Phase 2]

View source ↗

Summary

A Phase 2 trial of zanubrutinib in participants with active proliferative lupus nephritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• BRUKINSA (ZANUBRUTINIB)

Snippet

Sponsor: BeiGene | Conditions: Lupus Nephritis | Phase 2 | Status: COMPLETED